share_log

Atara Biotherapeutics Q1 2024 GAAP EPS $(0.23) Beats $(0.25) Estimate

Benzinga ·  May 9 16:46

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment